Lingfeng He

2.5k total citations
60 papers, 1.9k citations indexed

About

Lingfeng He is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lingfeng He has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Genetics. Recurrent topics in Lingfeng He's work include DNA Repair Mechanisms (15 papers), Epigenetics and DNA Methylation (13 papers) and RNA modifications and cancer (10 papers). Lingfeng He is often cited by papers focused on DNA Repair Mechanisms (15 papers), Epigenetics and DNA Methylation (13 papers) and RNA modifications and cancer (10 papers). Lingfeng He collaborates with scholars based in China, United States and United Kingdom. Lingfeng He's co-authors include Zhigang Guo, Zhigang Hu, Feiyan Pan, Chandrasekhar Kathera, Huan Wu, Xin Yuan, Fen Ma, Steven P. Balk, Adam G. Sowalsky and Housheng Hansen He and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Lingfeng He

56 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingfeng He China 24 1.4k 465 439 288 279 60 1.9k
Lijun Di China 25 1.0k 0.7× 602 1.3× 389 0.9× 180 0.6× 188 0.7× 102 1.9k
Jagadish C. Ghosh United States 20 1.5k 1.1× 355 0.8× 520 1.2× 232 0.8× 169 0.6× 30 1.9k
Junhong Han China 24 2.5k 1.7× 385 0.8× 463 1.1× 178 0.6× 160 0.6× 74 2.9k
Xiaohu Tang United States 28 1.8k 1.2× 516 1.1× 1.1k 2.4× 111 0.4× 281 1.0× 40 2.4k
Petra den Hollander United States 24 1.4k 1.0× 913 2.0× 596 1.4× 246 0.9× 227 0.8× 43 2.2k
Xianling Guo China 22 950 0.7× 492 1.1× 369 0.8× 92 0.3× 138 0.5× 47 1.7k
Leina Ma China 24 1.6k 1.1× 536 1.2× 793 1.8× 101 0.4× 164 0.6× 50 2.2k
Sven A. Lang Germany 24 928 0.7× 449 1.0× 298 0.7× 91 0.3× 174 0.6× 44 1.5k
Stéphanie Solier France 17 1.9k 1.3× 669 1.4× 406 0.9× 99 0.3× 168 0.6× 33 2.3k

Countries citing papers authored by Lingfeng He

Since Specialization
Citations

This map shows the geographic impact of Lingfeng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfeng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfeng He more than expected).

Fields of papers citing papers by Lingfeng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfeng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfeng He. The network helps show where Lingfeng He may publish in the future.

Co-authorship network of co-authors of Lingfeng He

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfeng He. A scholar is included among the top collaborators of Lingfeng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfeng He. Lingfeng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Lingfeng, Chonghua Li, X. G. Lei, et al.. (2025). SlHSFB2b-mediated inhibition of jasmonic acid catabolism enhances tomato tolerance to combined high light and heat stress. PLANT PHYSIOLOGY. 199(3).
3.
Chen, Jiannan, Lian‐Feng Zhao, Wenying Li, et al.. (2025). Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer. Journal of Translational Medicine. 23(1). 803–803. 3 indexed citations
4.
Du, Yu, Xinyu Yan, Feiyan Pan, et al.. (2024). APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell Death and Differentiation. 31(4). 431–446. 32 indexed citations
5.
Liu, Jie, Yan Zhang, Xinping Wang, et al.. (2024). m6A methyltransferase METTL3 promotes non-small-cell lung carcinoma progression by inhibiting the RIG-I-MAVS innate immune pathway. Translational Oncology. 51. 102230–102230. 4 indexed citations
6.
Guo, Luqin, Meng Cao, Yafei Li, et al.. (2023). RING finger ubiquitin E3 ligase CsCHYR1 targets CsATAF1 for degradation to modulate the drought stress response of cucumber through the ABA-dependent pathway. Plant Physiology and Biochemistry. 202. 107928–107928. 6 indexed citations
7.
Wang, Yuanyuan, Miaomiao Zhang, Jiannan Chen, et al.. (2023). FEN1 inhibitor SC13 promotes CAR‐T cells infiltration into solid tumours through cGAS–STING signalling pathway. Immunology. 170(3). 388–400. 7 indexed citations
8.
Li, Qianwen, Shan Shao, Chuanjun Shu, et al.. (2023). GAPDH facilitates homologous recombination repair by stabilizing RAD51 in an HDAC1 ‐dependent manner. EMBO Reports. 24(8). e56437–e56437. 6 indexed citations
9.
Xin, Jingyu, Lingfeng He, Zhigang Hu, et al.. (2023). RNA G-Quadruplex within the 5′-UTR of FEN1 Regulates mRNA Stability under Oxidative Stress. Antioxidants. 12(2). 276–276. 9 indexed citations
11.
Wu, Ting, Ge Chen, Lianfeng Zhao, et al.. (2022). A novel mechanism for macrophage pyroptosis in rheumatoid arthritis induced by Pol β deficiency. Cell Death and Disease. 13(7). 583–583. 31 indexed citations
12.
Li, Lulu, Ziyu Zhang, Yilan Zhang, et al.. (2021). Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer. Cell Death and Disease. 12(6). 503–503. 97 indexed citations
13.
Zhang, Miaomiao, Yongjing Yang, Jing Zhang, et al.. (2021). FEN1 inhibitor synergizes with low-dose camptothecin to induce increased cell killing via the mitochondria mediated apoptotic pathway. Gene Therapy. 29(7-8). 407–417. 5 indexed citations
14.
Wang, Wentao, Xingqi Zhao, Qianwen Li, et al.. (2021). Asymmetrical arginine dimethylation of histone H4 by 8-oxog/OGG1/PRMT1 is essential for oxidative stress-induced transcription activation. Free Radical Biology and Medicine. 164. 175–186. 19 indexed citations
15.
Xue, Xuling, Ying Fu, Liang He, et al.. (2021). Photoactivated Osmium Arene Anticancer Complexes. Inorganic Chemistry. 60(23). 17450–17461. 33 indexed citations
16.
Ye, Ying, Huaqing Zhong, Wei Song, et al.. (2021). Propranolol inhibits the angiogenic capacity of hemangioma endothelia via blocking β-adrenoceptor in mast cell. Pediatric Research. 92(2). 424–429. 7 indexed citations
17.
Wang, Meina, Lulu Li, Binghua Li, et al.. (2020). DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation. Oncogene. 39(33). 5507–5519. 17 indexed citations
18.
Zhang, Jing, Jing Li, Subee Tan, et al.. (2020). Inhibition of miR-1193 leads to synthetic lethality in glioblastoma multiforme cells deficient of DNA-PKcs. Cell Death and Disease. 11(7). 602–602. 17 indexed citations
19.
Wang, Meina, Lin Lin, Feiyan Pan, et al.. (2019). Enhanced Activity of Variant DNA Polymerase β (D160G) Contributes to Cisplatin Therapy by Impeding the Efficiency of NER. Molecular Cancer Research. 17(10). 2077–2088. 13 indexed citations
20.
Zhu, Hong, Xia Wen, Yilan Zhang, et al.. (2019). Inhibition of AKT Sensitizes Cancer Cells to Antineoplastic Drugs by Downregulating Flap Endonuclease 1. Molecular Cancer Therapeutics. 18(12). 2407–2420. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026